These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30360704)

  • 21. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of lysine biosynthesis: an evolving antibiotic strategy.
    Hutton CA; Perugini MA; Gerrard JA
    Mol Biosyst; 2007 Jul; 3(7):458-65. PubMed ID: 17579770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoproteins in bacteria: structures and biosynthetic pathways.
    Nakayama H; Kurokawa K; Lee BL
    FEBS J; 2012 Dec; 279(23):4247-68. PubMed ID: 23094979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in the research of inhibitors of enzymes of bacterial peptidoglycan biosynthesis].
    Liu F; Meng HY; Sun ZY; Li DY; Jin YY; Yang ZY; Wu SJ; Chen J
    Yao Xue Xue Bao; 2017 Mar; 52(3):362-70. PubMed ID: 29979555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies.
    Gonzalez-Bello C
    Curr Top Med Chem; 2016; 16(9):960-77. PubMed ID: 26303426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial targets in fatty acid biosynthesis.
    Wright HT; Reynolds KA
    Curr Opin Microbiol; 2007 Oct; 10(5):447-53. PubMed ID: 17707686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial DNA replication enzymes as targets for antibacterial drug discovery.
    Sanyal G; Doig P
    Expert Opin Drug Discov; 2012 Apr; 7(4):327-39. PubMed ID: 22458504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
    J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis.
    Ginsberg C; Zhang YH; Yuan Y; Walker S
    ACS Chem Biol; 2006 Feb; 1(1):25-8. PubMed ID: 17163636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzothiazole-based Compounds in Antibacterial Drug Discovery.
    Gjorgjieva M; Tomašič T; Kikelj D; Mašič LP
    Curr Med Chem; 2018; 25(38):5218-5236. PubMed ID: 28990510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review.
    Sangshetti JN; Joshi SS; Patil RH; Moloney MG; Shinde DB
    Curr Pharm Des; 2017; 23(21):3164-3196. PubMed ID: 28201974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three Principles of Diversity-Generating Biosynthesis.
    Gu W; Schmidt EW
    Acc Chem Res; 2017 Oct; 50(10):2569-2576. PubMed ID: 28891639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and Discovery of New Antibacterial Agents: Advances, Perspectives, Challenges.
    Jampilek J
    Curr Med Chem; 2018; 25(38):4972-5006. PubMed ID: 28925868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and development.
    Cipolla L; Polissi A; Airoldi C; Galliani P; Sperandeo P; Nicotra F
    Curr Drug Discov Technol; 2009 Mar; 6(1):19-33. PubMed ID: 19275539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traffic jam at the bacterial sec translocase: targeting the SecA nanomotor by small-molecule inhibitors.
    Segers K; Anné J
    Chem Biol; 2011 Jun; 18(6):685-98. PubMed ID: 21700205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ: Design, Synthesis, and Structure-Activity Relationships.
    Straniero V; Zanotto C; Straniero L; Casiraghi A; Duga S; Radaelli A; De Giuli Morghen C; Valoti E
    ChemMedChem; 2017 Aug; 12(16):1303-1318. PubMed ID: 28586174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential of bacterial fatty acid biosynthetic enzymes as a source of novel antibacterial agents.
    Payne DJ
    Drug News Perspect; 2004 Apr; 17(3):187-94. PubMed ID: 15179453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of prolipoprotein diacylglyceryl transferase (Lgt) and lipoprotein-specific signal peptidase II (LspA) in localization and physiological function of lipoprotein MsmE in Streptococcus mutans.
    Arimoto T; Igarashi T
    Oral Microbiol Immunol; 2008 Dec; 23(6):515-9. PubMed ID: 18954360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New strategies for antibacterial drug design: targeting non-multiplying latent bacteria.
    Coates AR; Hu Y
    Drugs R D; 2006; 7(3):133-51. PubMed ID: 16752940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.